405 related articles for article (PubMed ID: 30611543)
1. Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a).
Waldmann E; Parhofer KG
Pathology; 2019 Feb; 51(2):227-232. PubMed ID: 30611543
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein apheresis to treat elevated lipoprotein (a).
Waldmann E; Parhofer KG
J Lipid Res; 2016 Oct; 57(10):1751-1757. PubMed ID: 26889050
[TBL] [Abstract][Full Text] [Related]
3. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of different low-density lipoprotein apheresis methods.
Parhofer KG; Geiss HC; Schwandt P
Ther Apher; 2000 Oct; 4(5):382-5. PubMed ID: 11111821
[TBL] [Abstract][Full Text] [Related]
5. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.
Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
Atherosclerosis; 2018 Mar; 270():26-32. PubMed ID: 29407885
[TBL] [Abstract][Full Text] [Related]
6. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
Lee WP; Datta BN; Ong BB; Rees A; Halcox J
Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a)-apheresis in the light of new drug developments.
Vogt A
Atheroscler Suppl; 2017 Nov; 30():38-43. PubMed ID: 29096859
[TBL] [Abstract][Full Text] [Related]
8. Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease.
Otto C; Geiss HC; Laubach E; Schwandt P
Ther Apher; 2002 Apr; 6(2):130-5. PubMed ID: 11982953
[TBL] [Abstract][Full Text] [Related]
9. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
10. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany.
Heigl F; Hettich R; Lotz N; Reeg H; Pflederer T; Osterkorn D; Osterkorn K; Klingel R
Atheroscler Suppl; 2015 May; 18():154-62. PubMed ID: 25936320
[TBL] [Abstract][Full Text] [Related]
12. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre.
Mickiewicz A; Borowiec-Wolna J; Bachorski W; Gilis-Malinowska N; Gałąska R; Raczak G; Chmara M; Wasąg B; Jaguszewski MJ; Fijałkowski M; Gruchała M
Cardiol J; 2019; 26(6):669-679. PubMed ID: 30234904
[TBL] [Abstract][Full Text] [Related]
13. Current insights into the German Lipoprotein Apheresis Registry (GLAR) - Almost 5 years on.
Schettler VJJ; Neumann CL; Peter C; Zimmermann T; Julius U; Roeseler E; Heigl F; Grützmacher P; Blume H;
Atheroscler Suppl; 2017 Nov; 30():50-55. PubMed ID: 29096861
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
[TBL] [Abstract][Full Text] [Related]
15. Lipid apheresis techniques: current status in Germany.
Grützmacher P; Kleinert C
Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):20-3. PubMed ID: 22911177
[TBL] [Abstract][Full Text] [Related]
16. DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood.
Bosch T; Lennertz A; Schmidt B; Fink E; Keller C; Toepfer M; Dräger J; Samtleben W
Artif Organs; 2000 Feb; 24(2):81-90. PubMed ID: 10718759
[TBL] [Abstract][Full Text] [Related]
17. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
Koizumi J; Koizumi I; Uno Y; Inazu A; Kajinami K; Haraki T; Yagi K; Kamon N; Miyamoto S; Takegoshi T
Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
[TBL] [Abstract][Full Text] [Related]
18. How to optimize lipoprotein apheresis treatment--a second look.
Schettler V; Neumann CL; Hagenah GC; Schulz EG; Wieland E
Atheroscler Suppl; 2013 Jan; 14(1):89-92. PubMed ID: 23357148
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein apheresis in the management of severe hypercholesterolemia and hyperlipoproteinemia(a)-The Portuguese experience.
Ferreira L; Palma I; Bacelar C; Queirós JA; Madureira A; Oliveira JC; Ramos MH; Cardoso H
Transfus Apher Sci; 2018 Oct; 57(5):676-680. PubMed ID: 30287070
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
